Shared pathways: death receptors and cytotoxic drugs in cancer therapy.
about
Nonsteroidal anti-inflammatory drugs in colorectal cancer: from prevention to therapyEarly prediction of therapy response in patients with acute myeloid leukemia by nucleosomal DNA fragments.A novel aminosteroid of the 5α-androstane-3α,17β-diol family induces cell cycle arrest and apoptosis in human promyelocytic leukemia HL-60 cells.A hypothesis concerning a potential involvement of ceramide in apoptosis and acantholysis induced by pemphigus autoantibodies.mTOR controls FLIPS translation and TRAIL sensitivity in glioblastoma multiforme cellsThe fate of the terminally differentiated chondrocyte: evidence for microenvironmental regulation of chondrocyte apoptosis.P-glycoprotein is not involved in pathway of anti-Fas/Fas-induced apoptosis in KBv200 cells.A cell-based high-throughput screen to identify synergistic TRAIL sensitizers.Decitabine immunosensitizes human gliomas to NY-ESO-1 specific T lymphocyte targeting through the Fas/Fas ligand pathway.Mechanisms of apoptosis induction by nucleoside analogs.BID is a critical factor controlling cell viability regulated by IFN-α.Novel polymorphisms in caspase-8 are associated with breast cancer risk in the California Teachers StudyThe Amaryllidaceae isocarbostyril narciclasine induces apoptosis by activation of the death receptor and/or mitochondrial pathways in cancer cells but not in normal fibroblastsHuman agonistic TRAIL receptor antibodies Mapatumumab and Lexatumumab induce apoptosis in malignant mesothelioma and act synergistically with cisplatin.Use of APO2L/TRAIL with mTOR inhibitors in the treatment of glioblastoma multiforme.DDX3 regulates DNA damage-induced apoptosis and p53 stabilization.IER5 promotes irradiation- and cisplatin-induced apoptosis in human hepatocellular carcinoma cellsAnalysis of HIV Protease Killing Through Caspase 8 Reveals a Novel Interaction Between Caspase 8 and Mitochondria.Stereospecific induction of apoptosis in tumor cells via endogenous C16-ceramide and distinct transcriptsVorinostat and sorafenib increase ER stress, autophagy and apoptosis via ceramide-dependent CD95 and PERK activationBCL-2 family inhibitors enhance histone deacetylase inhibitor and sorafenib lethality via autophagy and overcome blockade of the extrinsic pathway to facilitate killing.Tapirira guianensis Aubl. Extracts Inhibit Proliferation and Migration of Oral Cancer Cells Lines.Keratins in colorectal epithelial function and disease.Unravelling mechanisms of cisplatin sensitivity and resistance in testicular cancer.Silibinin causes apoptosis and cell cycle arrest in some human pancreatic cancer cells.The acute and sensitization effects of tumor necrosis factor-α: implications for immunotherapy as well as psychiatric and neurological conditions.Steroidal aromatase inhibitors inhibit growth of hormone-dependent breast cancer cells by inducing cell cycle arrest and apoptosis.Silibinin triggers apoptosis and cell-cycle arrest of SGC7901 cells.Cellular and molecular mechanisms of silibinin induces cell-cycle arrest and apoptosis on HeLa cells.Bile salts differentially sensitize esophageal squamous cells to CD95 (Fas/Apo-1 receptor) mediated apoptosis.The death domain kinase RIP has an important role in DNA damage-induced, p53-independent cell death.Thermotolerance induced at a fever temperature of 40 degrees C protects cells against hyperthermia-induced apoptosis mediated by death receptor signalling.Avian sarcoma and leukosis virus cytopathic effect in the absence of TVB death domain signalingDown-regulation of sphingosine kinase-1 by DNA damage: dependence on proteases and p53.Dominant negative form of signal-regulatory protein-alpha (SIRPalpha /SHPS-1) inhibits tumor necrosis factor-mediated apoptosis by activation of NF-kappa B.Expressions of some vital molecules: glioblastoma multiforme versus normal tissues.Pyrrolidinium-type fullerene derivative-induced apoptosis by the generation of reactive oxygen species in HL-60 cells.Cyclin E overexpression enhances cytokine-mediated apoptosis in MCF7 breast cancer cells.Investigation of the effect of telmisartan on experimentally induced peripheral nerve injury in rats.Loss of drug-induced activation of the CD95 apoptotic pathway in a cisplatin-resistant testicular germ cell tumor cell line.
P2860
Q28195436-35A62B52-309F-413E-84B5-3EA9A0D6C1EDQ33245160-CD6F10B6-AF33-4C74-B8F3-19354C6A2EF9Q33708985-C522E166-D4A3-4A41-B451-063EE636408AQ33890589-C97ABC7C-1DB9-416B-B3C3-35D951B0D466Q34097241-92FA1777-EFD3-4F6F-873D-84100839C419Q35033466-8EE534E8-3C85-49DD-889A-37E7C9E68699Q35045233-74170BBC-9121-4AD5-ACDC-4E42B8A4B96FQ35200982-E7D6C671-E38F-488E-8551-7A769B07995AQ35589288-C1C3D5A4-3484-4D3D-B1C8-67E8A3901FB4Q35603389-ACB5D00D-D0DA-4CF1-8FD4-7023EFFF31E1Q35621716-61F4E053-46E0-4A87-8B06-43B0186154C9Q35892049-87D8E553-A945-4AA0-94A5-B4BF6185943BQ36012574-0417F576-CDB2-4269-A01B-2BAF09752D24Q36259724-1DD73183-CE35-4F35-81D0-4103868368D2Q36614009-811090D2-9B80-4E5F-83A6-F4F921FF18FEQ36802435-354A35CE-0F8E-4DBE-98A6-E48DCC59F4FAQ36879593-EDF42DD2-6A4A-4735-B3E9-9338FC81887DQ36901485-DAB0BA09-65B6-4B61-B0E2-E21AD70A388FQ37164339-DF70F0EA-D8AD-49AB-BFE5-4154C8D17FC0Q37172903-DFC67560-ECD4-40C2-85EF-2505B9D8F7BFQ37268123-09E1D8E5-66F4-4AD1-A39D-9E6B3F5676DCQ37465488-F121C2E4-1308-4D8A-BA61-78DFC9B4C59EQ38043040-0BDF41CA-5099-46DB-9379-24B3648F1652Q38145508-D2B195BB-CDDC-4F89-B941-EA00725E2B29Q38551068-E13F9234-6292-41D5-853F-F928EFC017FAQ38777671-80C5EC29-A797-4CD3-AA3F-F2FCA8456333Q39127733-39A9D43D-057B-4434-AEB3-CD12AB88AFB8Q39343970-B6B19F3A-6F7A-41F5-97EC-DE4FE4251C98Q39428445-1B730103-2AD8-4F0E-BE0B-434EAD64013BQ39646130-F62B9717-87CD-4C34-83AF-3EDDAA538AA2Q40258141-626D8DD5-C2D5-4557-8116-7C94BA97AABFQ40402021-D575B072-5560-4CE3-9B4E-5BDE1C85028FQ40409670-632840C4-1C58-43D3-9BC9-3CA4D04C3C6AQ40584948-2BBBCB01-0DA3-439B-9962-701B710D377DQ42807953-58D2BDAD-FCA4-4A8E-92AD-81DA74041084Q43186987-79F29894-3ABA-466D-8AD6-9659CA48C744Q43244383-EEB9AEFF-48C6-404E-963C-66FC0E234DB8Q46090981-ED0A905D-9DF8-4F11-909D-138448886333Q46188427-C0970B32-ACB2-4031-AC5F-A29DE72685FCQ53926583-177F0DD5-0F20-4CA9-BB84-54B42B1D9889
P2860
Shared pathways: death receptors and cytotoxic drugs in cancer therapy.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Shared pathways: death receptors and cytotoxic drugs in cancer therapy.
@ast
Shared pathways: death receptors and cytotoxic drugs in cancer therapy.
@en
Shared pathways: death receptors and cytotoxic drugs in cancer therapy.
@nl
type
label
Shared pathways: death receptors and cytotoxic drugs in cancer therapy.
@ast
Shared pathways: death receptors and cytotoxic drugs in cancer therapy.
@en
Shared pathways: death receptors and cytotoxic drugs in cancer therapy.
@nl
prefLabel
Shared pathways: death receptors and cytotoxic drugs in cancer therapy.
@ast
Shared pathways: death receptors and cytotoxic drugs in cancer therapy.
@en
Shared pathways: death receptors and cytotoxic drugs in cancer therapy.
@nl
P2860
P356
P1476
Shared pathways: death receptors and cytotoxic drugs in cancer therapy.
@en
P2093
P2860
P2888
P304
P356
10.1007/BF03032574
P577
2001-01-01T00:00:00Z